Literature DB >> 21102240

Vaccines and immunotherapy for non-small cell lung cancer.

Daniel Morgensztern1, Boone Goodgame, Ramaswamy Govindan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21102240     DOI： 10.1097/01.JTO.0000391367.63882.79

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Ipilimumab: its potential in non-small cell lung cancer.

Authors:  Pascale Tomasini; Nataliya Khobta; Laurent Greillier; Fabrice Barlesi
Journal:  Ther Adv Med Oncol       Date:  2012-03       Impact factor: 8.168

2.  Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.

Authors:  Juan Wang; Ze-Hong Zou; Hong-Lin Xia; Jian-Xing He; Nan-Shan Zhong; Ai-Lin Tao
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

3.  Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines.

Authors:  Narasimha Kumar Karanam; Kalayarasan Srinivasan; Lianghao Ding; Brock Sishc; Debabrata Saha; Michael D Story
Journal:  Cell Death Dis       Date:  2017-03-30       Impact factor: 8.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.